Expansion opportunities Pace Analytical has recently expanded its life sciences capabilities and laboratory network, suggesting potential upsell possibilities to pharmaceutical and biopharma clients needing comprehensive testing, regulatory consulting, and onsite lab support.

New assay capability Launched ultrashort-chain PFAS testing method presents a specific niche for environmental and compliance-focused clients seeking advanced contaminant analysis and regulatory readiness.

Leadership & growth Key leadership appointments and recent acquisitions signal a growth trajectory and increased R&D emphasis, providing a talking point to engage mid-market life science and environmental firms looking for stable, ambitious testing partners.

Awards & credibility Environmental Business Journal award for respirable crystalline silica testing enhances credibility with clients in regulated industries who require validated, quality-assured analytical services.

Strategic partnerships Recent partnerships with Aspire Biolabs and integration of multiple lab assets indicate a capacity to support contracted development, formulation, batch manufacturing, and stability studies for pharma and biotech customers.